Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data

Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data

Ernexa Therapeutics Inc. reported Wednesday that its lead cell therapy, ERNA-101, paired with PD-1 blockade, wiped out tumors completely and delivered 100% long-term survival in preclinical ovarian cancer studies. “Complete tumor eradication and durable survival,” is how Chief Scientific Officer Robert H. Pierce summed up the results. Chief Executive Sanjeev Luther called the data “beyond expectations.”
6 May 2026
···
US Stock Market Today: S&P 500 and Nasdaq Hit Records as AMD Rally, Oil Drop Shake Wall Street

US Stock Market Today: S&P 500 and Nasdaq Hit Records as AMD Rally, Oil Drop Shake Wall Street

Stocks barreled higher Wednesday, driving the S&P 500 and Nasdaq to new records. Advanced Micro Devices gave the AI trade another jolt with a strong forecast, while reports of movement on a U.S.-Iran agreement knocked oil down. By 12:30 p.m. ET, the Dow climbed 510.85 points, or 1.04%, landing at 49,809.10. The S&P 500 advanced 82.14 points, or 1.13%, to 7,341.36. Nasdaq surged 395.68 points, or 1.56%, to 25,717.84.
6 May 2026
·····
Coupang Stock Slides After $266 Million Q1 Loss, and the Data-Breach Bill Is Still Coming Due

Coupang Stock Slides After $266 Million Q1 Loss, and the Data-Breach Bill Is Still Coming Due

Coupang Inc. shares took a 16.6% hit to $17.32 in early afternoon trading in New York on Wednesday, pressured by a $266 million net loss for the first quarter. The South Korea-focused e-commerce company blamed higher compensation and network expenses stemming from last year’s data breach for the red ink in the January–March stretch. MarketScreener provided the trading data.
6 May 2026
····
SolarEdge Stock Slides After Earnings Miss as Turnaround Faces a Harder Test

SolarEdge Stock Slides After Earnings Miss as Turnaround Faces a Harder Test

Shares of SolarEdge Technologies slipped roughly 6% by late Wednesday morning. The solar-equipment firm posted a deeper adjusted first-quarter loss than Wall Street had braced for, even as sales came in ahead of estimates and guidance pointed to near-breakeven operations next quarter. SolarEdge was changing hands at $41.91, having dipped to $37.83 earlier in the session.
6 May 2026
··
Avalo Therapeutics Stock Jumps As $375 Million Raise Follows Phase 2 HS Trial Win

Avalo Therapeutics Stock Jumps As $375 Million Raise Follows Phase 2 HS Trial Win

Late Tuesday, Avalo Therapeutics Inc. locked in a $375 million public offering—just hours after rolling out upbeat Phase 2 results for abdakibart. Riding the surge of interest tied to its hidradenitis suppurativa program, the company aims to fund its looming Phase 3 plans. Avalo is set to offer 19.73 million shares at $17.75 apiece, along with pre-funded warrants for another 1.4 million shares at $17.749 each. Closing is slated for May 7, pending standard closing conditions.
6 May 2026
··
1 … 107 108 109 110 111 … 891
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

CACI International

NYSE: CACI 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 93 / 100
#3 BUY

AerCap

NYSE: AER 91 / 100
#4 BUY ON PULLBACK

Motorola Solutions

NYSE: MSI 89 / 100
#5 ACCUMULATE

Walt Disney

NYSE: DIS 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.